B+
Bull case
20%
Probability
Target price
$1.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
ARTL
Artelo BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
ART26.12 has encouraging company-reported preclinical pain data and a potentially differentiated safety profile, creating asymmetric upside if clinical translation succeeds [#PR-EARNINGS-2026-07-16].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
No confirmed dated clinical, regulatory, partnering, or financing milestone is available.
Momentum
1
Value
58
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.68 · Bull $1.50 · Bear $0.30Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum1 · Δ7d -
Value58 · Δ7d -0.2
Sentiment0 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • No confirmed dated clinical, regulatory, partnering, or financing milestone is available.
- • No recent news set, social coverage, or analyst revision data is available.
- • The company is a roughly $2.6 million micro-cap biotech with limited forward visibility.
Catalyst clock
2026-07-16
ART26.12 osteoarthritis nonclinical data
Lead driver: Value · See fundamentals
Momentum
1
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.4
Sentiment
0
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 1.1 / Value 57.9 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.68
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.30
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$1.4M
Beta
1.11
Shares Out
547.77K
P/E (TTM) · Derived
-0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.12
Rev YoY
-
EPS YoY
-94.7%
Gross Margin
-
Op Margin
-
Net Debt
$78K
Current Ratio
3.00
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data